Auromedics Pharma

Cyclophosphamide

Manufacturer:

Auromedics Pharma

Cyclophosphamide HCPCS:

J9071

HCPCS Code Descriptor:

Injection, cyclophosphamide, (auromedics), 5 mg

Category:

J Code

Cyclophosphamide NDCs:

55150-0271-01, 55150-0270-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Cyclophosphamide:

Cyclophosphamide is an Oncology drug manufactured by Auromedics Pharma and administered via the Intravenous route of administration. The J Code: J9071 is aligned to the drug Cyclophosphamide.

ACCESS PRICING AND MORE BY REGISTERING

J9071 Added Date:

April 1, 2022

J9071 Effective Date:

April 1, 2022

J9071 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cyclophosphamide billing and coding information.
Cyclophosphamide patient assistance information can be found through AmeriPharma at the URL: https://ameripharmaspecialty.com/cyclophosphamide-copay-assistance/
Cyclophosphamide prescribing information can be found at the link below:
Information regarding Cyclophosphamide’s side effects can be found at MedlinePlus